Pardeep Nijhawan - Nov 2, 2022 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Pardeep Nijhawan
Stock symbol
EDSA
Transactions as of
Nov 2, 2022
Transactions value $
$513,590
Form type
4
Date filed
11/4/2022, 03:27 PM
Previous filing
Jul 5, 2022
Next filing
Jul 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDSA Common Shares Award $257K +228K +10.72% $1.13 2.36M Nov 2, 2022 Held by Pardeep Nijhawan Medicine Professional Corporation F1, F2
transaction EDSA Common Shares Award $257K +228K $1.13 228K Nov 2, 2022 By Trust F1
holding EDSA Common Shares 595K Nov 2, 2022 Direct
holding EDSA Common Shares 224K Nov 2, 2022 Held by The Digestive Health Clinic Inc. F2
holding EDSA Common Shares 372K Nov 2, 2022 Held by 1968160 Ontario Inc. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDSA Common Share Warrants (Right to Buy) Award +114K 114K Nov 2, 2022 Common Shares 114K $1.50 Held by Pardeep Nijhawan Medicine Professional Corporation F1, F2, F3
transaction EDSA Common Share Warrants (Right to Buy) Award +114K 114K Nov 2, 2022 Common Share 114K $1.50 By Trust F1, F3
transaction EDSA Common Share Warrants (Right to Buy) Award +114K 114K Nov 2, 2022 Common Shares 114K $1.00 Held by Pardeep Nijhawan Medicine Professional Corporation F1, F2, F4
transaction EDSA Common Share Warrants (Right to Buy) Award +114K 114K Nov 2, 2022 Common Share 114K $1.00 By Trust F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share.
F2 Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan.
F3 Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date.
F4 Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date.